Dolby Laboratories (NYSE:DLB – Get Free Report) updated its FY 2025 earnings guidance on Tuesday. The company provided EPS guidance of 3.990-4.140 for the period, compared to the consensus EPS estimate of 3.700. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.3 billion. Dolby Laboratories also updated its FY25 guidance to $2.43-2.58 EPS.
Analyst Upgrades and Downgrades
DLB has been the topic of a number of research reports. StockNews.com raised shares of Dolby Laboratories from a “buy” rating to a “strong-buy” rating in a research note on Monday. Barrington Research reaffirmed an “outperform” rating and issued a $100.00 target price on shares of Dolby Laboratories in a research report on Friday, September 20th. Finally, Rosenblatt Securities lifted their price target on Dolby Laboratories from $98.00 to $100.00 and gave the company a “buy” rating in a report on Wednesday.
Dolby Laboratories Trading Down 0.6 %
Dolby Laboratories announced that its board has initiated a stock repurchase program on Wednesday, August 7th that authorizes the company to buyback $350.00 million in shares. This buyback authorization authorizes the electronics maker to buy up to 5% of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s board believes its stock is undervalued.
Insider Activity
In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 28,512 shares of the company’s stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of $74.12, for a total transaction of $2,113,309.44. Following the completion of the sale, the chief executive officer now owns 83,721 shares of the company’s stock, valued at $6,205,400.52. This represents a 25.40 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 39.54% of the stock is currently owned by insiders.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Featured Articles
- Five stocks we like better than Dolby Laboratories
- What Does Downgrade Mean in Investing?
- Berkshire Buys POOL Stock: Is It Time to Take the Plunge?
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- 93% Gain for Impinj Stock—Here’s Why It Could Climb Higher
- Low PE Growth Stocks: Unlocking Investment Opportunities
- The Trade Desk: When Sell the News Turns Into Buy the Dip
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.